Stephens Investment Management Group LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 528,464 shares of the biotechnology company’s stock after selling 17,490 shares […]